Trinity Biotech | TRIB - Cost Of Sales

Stock Price
0.71
Daily Change
-0.01 -1.53%
Monthly
-21.74%
Yearly
-2.87%
Q1 Forecast
0.69

Trinity Biotech reported $7.84M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Abbott USD 4.92B 535M Dec/2025
Bayer EUR 4.31B 57M Sep/2025
Bio-Rad Laboratories USD 309.6M 3.3M Sep/2025
EDAP TMS EUR 9.22M 1.36M Jun/2025
J&J USD 7.97B 689M Dec/2025
Mesa Laboratories USD 21.92M 1.78M Sep/2024
OraSure Technologies USD 22.84M 6.8M Sep/2024
Roche Holding CHF 8.48B 4.61B Dec/2025
Siemens EUR 11.51B 1.82B Dec/2025
Surmodics USD 33.03M 24.58M Sep/2024
Thermo Fisher Scientific USD 7.58B 674M Dec/2025
Tosoh JPY 190.27B 3.82B Dec/2025
Trinity Biotech USD 7.84M 3.14M Sep/2025
Veracyte USD 39.28M 1.93M Dec/2025